Publication:

Antagonists of Wnt and BMP signaling promote the formation of vertebrate head muscle

Loading...
Thumbnail Image

Date

2003

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Cold Spring Harbor Laboratory Press
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Tzahor, E. 2003. “Antagonists of Wnt and BMP Signaling Promote the Formation of Vertebrate Head Muscle.” Genes & Development 17 (24) (December 15): 3087–3099.

Abstract

Recent studies have postulated that distinct regulatory cascades control myogenic differentiation in the head and the trunk. However, although the tissues and signaling molecules that induce skeletal myogenesis in the trunk have been identified, the source of the signals that trigger skeletal muscle formation in the head remain obscure. Here we show that although myogenesis in the trunk paraxial mesoderm is induced by Wnt signals from the dorsal neural tube, myogenesis in the cranial paraxial mesoderm is blocked by these same signals. In addition, BMP family members that are expressed in both the dorsal neural tube and surface ectoderm are also potent inhibitors of myogenesis in the cranial paraxial mesoderm. We provide evidence suggesting that skeletal myogenesis in the head is induced by the BMP inhibitors, Noggin and Gremlin, and the Wnt inhibitor, Frzb. These molecules are secreted by both cranial neural crest cells and by other tissues surrounding the cranial muscle anlagen. Our findings demonstrate that head muscle formation is locally repressed by Wnt and BMP signals and induced by antagonists of these signaling pathways secreted by adjacent tissues.

Description

Other Available Sources

Research Data

Keywords

Skeletal myogenesis, cranial neural crest, head mesoderm, Wnt, BMP, Noggin, Gremlin, Frzb

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories